These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12856428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immunotherapy of malignant diseases].
    Dorval T, Michon J, Tartour E, Fridman WH.
    Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biological response modifier--immunotherapeutic approaches in pancreatic cancer.
    Schmiegel W.
    Hepatogastroenterology; 1989 Dec; 36(6):456-8. PubMed ID: 2693301
    [Abstract] [Full Text] [Related]

  • 6. Biologicals and biological response modifiers: fourth modality of cancer treatment.
    Oldham RK.
    Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
    [Abstract] [Full Text] [Related]

  • 7. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA, Hu P, Epstein AL.
    Handb Exp Pharmacol; 2008 Jan; (181):291-328. PubMed ID: 18071951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytokines.
    Holmlund JT.
    Cancer Chemother Biol Response Modif; 1993 Jan; 14():150-206. PubMed ID: 7508728
    [No Abstract] [Full Text] [Related]

  • 10. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytokine-based therapy and biochemotherapy for advanced melanoma.
    Atkins MB.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurologic complications of cytokine therapy.
    Forman AD.
    Oncology (Williston Park); 1994 Apr 01; 8(4):105-10; discussion 113, 116-7. PubMed ID: 8003395
    [Abstract] [Full Text] [Related]

  • 16. Recombinant bispecific antibodies for cellular cancer immunotherapy.
    Müller D, Kontermann RE.
    Curr Opin Mol Ther; 2007 Aug 01; 9(4):319-26. PubMed ID: 17694444
    [Abstract] [Full Text] [Related]

  • 17. Novel antibodies as anticancer agents.
    Zafir-Lavie I, Michaeli Y, Reiter Y.
    Oncogene; 2007 May 28; 26(25):3714-33. PubMed ID: 17530025
    [Abstract] [Full Text] [Related]

  • 18. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M, Mohr L, Ali MY, Grimm CF, Ritter M, Blum HE.
    Z Gastroenterol; 2003 Nov 28; 41(11):1101-10. PubMed ID: 14648380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.